Home » Topics » BioWorld Science

BioWorld Science
RSS

Secarna Pharmaceuticals patents novel anti-CD39 immunosuppression-reverting oligonucleotides

May 8, 2018

Delcath initiates pivotal trial of melphalan in intrahepatic cholangiocarcinoma

May 8, 2018

Novel formulation of ribaxamase protects the gut microbiome

May 8, 2018

Procella and Smartwise establish cardiovascular collaboration with AstraZeneca

May 8, 2018

Bill & Melinda Gates Foundation grant supports Recursion's expansion into malaria

May 8, 2018

Novel BET bromodomain inhibitor TG-1601 a clinical candidate

May 8, 2018

HM-81422 as a novel treatment option for patients with HCC with altered FGF19/FGFR4 pathway

May 8, 2018

FDA approves IND for female hair loss trial of Histogen's HSC-660

May 7, 2018

New mutation in SLC20A2 gene found in Fahr's disease

May 7, 2018

ORR data from KEYNOTE-407 trial of Keytruda in first-line NSCLC support sBLA submission

May 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...